The future of immuno-oncology drug development is positioned in combination therapies, where immunotherapy modalities are tested in rational...
The Immuno-Oncology Biomarkers Workshop will identify the next steps for action in immunotherapy biomarker development. It will provide a forum for...
Uncontrolled inflammation is the underlying pathological mechanism of a variety of infectious and non-infectious diseases that together are...
Single cell omics is a new frontier in biology where genome-wide data is captured at the resolution of individual cells. Single cell high-throughput...